0
Transplantation: Outcomes in Lung Transplantation Slide |

Prevalence of Donor Specific Antibodies and Its Association With Lung Transplant Outcomes: A Single-Center Experience

Daniel Sullivan, MD; Fernando Torres, MD; Amit Banga, MD; Manish Mohanka, MD; Srinivas Bollineni, MD; Jessica Mullins, MD; Usha Rao, MD; Chantale Lacelle, PhD; Pavan Duddupudi; Dhiraj Surapaneni; Vaidehi Kaza, MD
Author and Funding Information

The University of Texas Southwestern Medical Center, Department of Internal Medicine, Dallas, TX


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(4_S):1307A. doi:10.1016/j.chest.2016.08.1423
Text Size: A A A
Published online

Extract

SESSION TITLE: Outcomes in Lung Transplantation Slide

SESSION TYPE: Original Investigation Slide

PRESENTED ON: Monday, October 24, 2016 at 01:30 PM - 02:30 PM

PURPOSE: Development of donor specific antibodies (DSA) is common after lung transplantation (LT). It is considered a risk factor for bronchiolitis obliterans syndrome (BOS), a phenotype of chronic lung allograft dysfunction (CLAD). BOS is the major limitation for long term survival after LT. The aim of our study was to evaluate the association of prevalence and strength of DSA on survival and time to BOS.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543